OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Outset Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$3.80−0.14 (-3.55%)

Close on Oct 19, 2026

Market cap: $70.75K
P/E (TTM): –
Dividend yield: –

Outset Medical, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Revenue	119	114	130	115	103	50	15	2.01
Cost of Revenue	73	75	101	98	95	63	33	8.12
Gross Profit	47	39	29	18	7.61	-13	-18	-6.12
Research & Development	21	38	57	49	37	29	23	23
Selling, General & Admin	92	114	141	130	101	76	29	18
Selling & Marketing	54	70	96	89	65	45	20	11
General & Administrative	38	43	45	41	36	31	8.92	6.25
Advertising Expenses	0	0	0	0	0	0	0	0
Operating Expenses	113	152	199	179	138	104	53	40
Operating Income	-67	-113	-170	-161	-131	-117	-70	-47
Interest Expense	14	24	13	3.57	1.72	2.89	4.26	4.64
Other Non-Operating Income	7.41	9.76	10	3.29	0.50	0.53	2.49	1.71
Merger & Restructuring Charges	0.03	–	–	–	–	–	–	–
Asset Impairment Charges	0	0	0	0	0	0	0	–
Gain (Loss) on Sale of Assets	-0.01	-0.05	-0.11	-0.04	-0.08	-0.24	-0.29	–
Pretax Income	-81	-127	-172	-163	-132	-121	-68	-50
Income Tax Expense	0.72	0.49	0.52	0.30	0.20	0	0.02	0.03
Net Income	-82	-128	-173	-163	-132	-121	-68	-50
EPS (Basic)(per share)	-5.37	-36.96	-52.28	-50.70	-43.35	-72.75	-1,493.70	-1,511.25
EPS (Diluted)(per share)	-5.37	-36.96	-52.28	-50.70	-43.35	-72.75	-1,493.70	-1,511.25
Shares Outstanding (Basic, Weighted)(shares)	0.02	0.00	0.00	0.00	0.00	0.00	0.06	0.05
Shares Outstanding (Diluted, Weighted)(shares)	0.02	0.00	0.00	0.00	0.00	0.00	0.06	0.05
EBITDA	-62	-108	-164	-156	-125	-114	-69	-45

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 41.8%
Operating margin: -56.1%
Net margin: -63.1%
Return on equity, FY2025: -106.2%

Financial strength

Current ratio: 5.19
Debt to equity: 1.01
Debt to assets: 40.3%
Cash to current liabilities: 79.8%

Valuation

P/E ratio: –
Price to sales: 0.00
Price to book: 0.00
Dividend yield: –